After the full approval, Pfizer and BioNTech can market the vaccine directly to the consumers. For people above the age of 16 years will receive the vaccine under the name of Comirnaty. Whereas, people aging between 12 to 15 will be administered with the shot after having an emergency use authorization.
With the full approval by FDA, the Pfizer vaccine can now easily be believed to meet all the high safety standards. This secures most of the public’s confidence. Moreover, this approval will also provoke people who were scared of the side effects of these vaccines to get their shots.